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Background: Novel physiotherapy approaches such as motor imagery and rhythmic auditory stimulation have
been shown to improve walking in people with multiple sclerosis (MS). Rhythmic cued motor imagery was used in
this study, whose objectives were to evaluate the feasibility of a larger randomised controlled trial (RCT) in people
with MS and to obtain information on walking.
Methods: Thirty adult people with MS who scored 1.5–4.5 on the Expanded Disability Status Scale were recruited
at the MS Clinic Innsbruck, Austria. Participants were randomly allocated to one of three groups, all receiving usual
care: 17 min of motor imagery, six times per week, for 4 weeks, with music (A) or metronome cues (B) and (C) controls.
Primary outcomes were recruitment rates, retention, compliance, adverse events and fatigue (Modified Fatigue Impact
Scale). Secondary outcomes were walking speed (Timed 25-Foot Walk) and walking distance (6-Minute Walk Test).
Results: We achieved our recruitment target by recruiting 12 participants per month, a mean eligibility rate of 40.1 %
(95 % confidence interval (CI) 35.8, 44.6 %) out of 2500 MS Centre patients, mean consent rate of 15.9 % (95 % CI 11.3,
21.7 %) plus 54.5 % (95 % CI 47.4, 61.4 %) of eligible patients who expressed their interest to participate. Retention of
100 %, no adverse events, good compliance, high acceptability of the interventions and no worsening of fatigue
confirmed feasibility. The mean improvement in walking speed in both groups A and B was −0.9 s (95 % CI −1.3, −0.5),
and mean worsening in group C was 0.4 s (95 % CI −0.3, 1.1). The mean improvement in walking distance in group A
was 68.1 m (95 % CI 51.4, 84.7) and in group B 92.9 m (95 % CI 55.2, 130.5), and mean worsening in group C was −9.4 m
(95 % CI −35.6, 16.9).
Conclusions: Results from our study showed that a full-scale RCT is feasible to investigate the effects of rhythmic cued
motor imagery on walking in people with MS, with no changes to the interventions and assessments. Based on
the walking improvements, a total sample size of 138 participants was calculated. Stratified blocked randomisation,
allocation concealment and blinding will be used in the main study.
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Multiple sclerosis (MS) is an inflammatory demyelinating
disease of the central nervous system affecting a person’s
ability to walk, participation and quality of life [1]. Many
people with MS adopt a sedentary lifestyle due to walking
impairment [2] with 60 to over 90 % having walking prob-
lems [3]. In particular, reduced walking speed has a direct
impact leading to reduced activities of daily living [3].
Physiotherapy has been shown to be effective in improving
the individuals’ walking [4].
Recently, novel physiotherapy strategies, such as motor
imagery and rhythmic auditory stimulation have been de-
veloped to improve walking speed and distance in people
with neurologic disorders. Motor imagery is the mental
execution of movements without any actual movement per-
formance [5]. The advantage of motor imagery over actual
movement practice is that it does not cause motor fatigue
and the person is not at risk of falls as it can be practised
while seated. Only one uncontrolled study was identified
that investigated the effect of 5 weeks of motor imagery
training on fatigue, walking and quality of life in 20 people
with MS, with a median Expanded Disability Status Scale
(EDSS) score of 2.0 (range 1.0, 6.0), corresponding with
mild to moderate MS [6]. Results from their study were sig-
nificant improvements in fatigue and quality of life, without
effect sizes reported, but only trends for improvement in
walking. To our knowledge, so far, no studies have investi-
gated the effects of rhythmic cued motor imagery on walk-
ing performance in people with MS.
In people with other neurologic disorders, motor im-
agery has been shown to improve motor performance,
in particular in people with stroke [7, 8], with moderate
effect sizes [8]. Two different perspectives can be adopted
during motor imagery, an internal, first-person (kinaesthetic
mode) or an external, third-person (visual mode) perspec-
tive [5]. In the kinaesthetic mode, the person experiences/
feels his or her own body moving, and in the visual mode,
the person imagining watches himself or herself. For motor
imagery of walking, individuals need to be ambulatory since
there is a relationship between mental and physical execu-
tion of a movement [9]. It has been demonstrated that in
people with motor impairment, the kinaesthetic mode is
more effective than the visual mode because of a more effi-
cient motor learning [10] due to sensory information [11];
therefore, the kinaesthetic imagery has been adopted for
the current study.
Motor imagery can be practised with or without ver-
bal guiding and additional, visual or auditory, cues [10].
Heremans and colleagues demonstrated that in people
with moderate to severe MS, motor imagery ability cor-
related more with cognitive than physical impairment
during an upper limb task [12] and was enhanced by
rhythmic auditory cues [13]; therefore, rhythmic auditory
cues were used in the current study.Rhythmic auditory stimulation is another novel physio-
therapy approach in walking rehabilitation which uses
rhythmic auditory cues to synchronise the person’s steps
with the external rhythm [14, 15]. It has been shown that
intrinsically rhythmic movements such as walking are fa-
cilitated most effectively by even, rhythmic pulses [16].
Rhythmic auditory stimulation with metronome cues ver-
sus rhythmically accentuated music has been investigated
in different populations. Studies have found that music
but not metronome cues at the same tempo led to a sig-
nificant increase in walking speed in healthy individuals
[17, 18], with moderate effect sizes [17]. The authors sug-
gested that additional auditory elements in the music may
have facilitated walking more than simple metronome
cues. Rhythmic auditory stimulation was shown to im-
prove walking in people with neurologic disorders other
than MS [19, 20, 16], with high effect sizes in people with
Parkinson’s disease [20]. In people with MS, only two
small studies investigated the effect of rhythmic auditory
stimulation on walking [21, 22]. Baram and Miller [21]
used a metronome-based auditory feedback device in 14
patients with a median EDSS score of 4.5 (range 4, 6) and
corresponding to moderate MS, to measure effects on
walking speed and gait parameters, in comparison to 11
healthy controls. Results showed a 12.84 % improvement
in walking speed and an 8.30 % improvement in stride
length, but effect sizes were not reported. Conklyn and
colleagues’ [22] home-based pilot study in 10 persons with
MS used music with embedded metronome cues and gait
training, which resulted in significant improvement in per-
centage double support time with moderate effects sizes
in the treatment group.
According to our knowledge and a recent meta-analysis
[23], to date, no other randomised controlled trials have
investigated the effect of motor imagery combined with
rhythmic auditory stimulation on walking in people with
MS, whereas this approach was applied in people with
stroke. In their pilot study, Kim et al. found significantly
improved walking performance in people with stroke
(n = 15), in particular with kinaesthetic motor imagery
when compared to visual motor imagery and with audi-
tory step rhythm in comparison to without [24]. No effect
sizes of the improvements were reported.
Recent work supports our basic suggestion that the
connections between rhythmic auditory and motor pro-
cessing, that is sensorimotor synchronisation to rhythmic
auditory stimuli, may also apply to motor imagery [25].
Additionally, music has various other beneficial influences,
such as its ability to improve mood, to increase the amount
of work a person does while listening and to enhance mo-
tivation [26, 18] which might impact on walking perform-
ance and imagined walking. Listening to music instead of a
metronome might be more pleasurable which might in-
crease adherence to the motor imagery in our study, which
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some participants might be distracted by the music and
feel more comfortable with the metronome. Although
motor imagery does not cause physical fatigue, it might
induce mental fatigue which needs to be tested. Therefore,
a subtle emphasis was put on the beat, using simple and
concise verbal cues to provide a more precise metrical
structure which might facilitate rhythmic entrainment and
attention in participants [14]. Verbal cues were used to
prompt one specific component of imagined walking, like
taking long strides [27]. This was the rationale for con-
ducting a pilot study in which motor imagery with metro-
nome or musical rhythm were compared with each other
and against a control group.
The first aim of the study was to test the feasibility of
a full-scale randomised controlled trial (RCT). The second
aim of the study was to evaluate changes in fatigue caused
by rhythmic cued motor imagery, as increased fatigue
might be a barrier to the main study. The third aim of the
study was to obtain information on walking speed and
walking distance to be able to calculate the sample size for
the main study.
Methods
Prior to study commencement, an MS advisory group
selected from a self-help group had been consulted for
advice, to clarify any questions, for example, in terms of
their motor imagery ability or whether they had prac-
tised it previously, and their music preference, but also
on the question of how much time they would spend on
practising. Comments from the advisory group members
were very valuable to the researchers as they provided
an insight into the patients’ perspectives. In response to
this input, for group A, motivating music with a pleasing
melody was selected, and for group B, metronome cues
with different tone pitches were chosen.
The study was a three-group parallel randomised con-
trolled single-centre pilot trial to provide information for
a subsequent larger randomised controlled trial. There-
fore, the sample size was based on the specific objectives
of the study such as feasibility, attrition, adverse events
and calculation of the sample size for the main study ra-
ther than on the estimated effects of the interventions.
The pilot study involved 30 people with MS and com-
pared participants in three equally sized groups: motor
imagery with rhythmically accentuated music and verbal
cueing (group A), motor imagery with metronome cues
and verbal cueing (group B) and a control group (group
C). Participants in all groups received usual care and
weekly phone calls. The study was conducted as follows:
Initial visit to clinic for baseline assessment and instruc-
tion and provision of compact disc (CD), home-based
intervention, then participants were contacted by phone
once weekly to support the use of CD and to addressany study related questions. Participants returned for re-
assessment after completing the 4-week intervention.
Blinding was not possible as one physiotherapist (BS)
was conducting the intervention instructions and assess-
ments, and the participants became aware whether they
were in an intervention or control arm. The measurements
were taken at the MS Clinic of the Clinical Department of
Neurology, Medical University of Innsbruck, Austria.
Ethic statement
The study was approved by the Faculty Research Ethics
Governance Committee of the University of Brighton on
9 January 2014 (reference number 13 053) and the Ethics
Committee of the Medical University of Innsbruck on 2
April 2014 (reference number AN2014-0052 334/4.14).
All participants provided written informed consent. Partic-
ipants were reimbursed for travel expenses only.
Participants and recruitment
Recruitment used unselected consecutive sampling and
restricted randomisation from 9 April to 16 June 2014.
A CONSORT flow diagram is shown in Fig. 1.
Inclusion criteria were people with mild to moderate
MS (Expanded Disability Status Scale, EDSS 1.5 to 4.5)
[28], aged 18 years or over, MS according to McDonald’s
criteria [29], all MS phenotypes, any ethnicity, German
speaking (questionnaires, instructions).
Exclusion criteria were concomitant other diseases
which may affect rhythmic cued motor imagery or walking
(e.g. untreated hearing impairment), a relapse of MS within
the last 3 months, recent change of medication which is
known to affect walking within the last 2 months, known
pregnancy, overt symptoms or signs of depression or cogni-
tive dysfunction, diagnosed and documented by Innsbruck
MS Clinics. A relapse during the intervention period led to
exclusion of the participant.
Participants were allocated randomly by drawing sealed
envelopes from a black bag, with letters ‘A’, ‘B’ or ‘C’ which
were consistent with the three study groups. The re-
searchers aimed at 10 participants in each group so that the
randomisation was restricted insofar as the bag contained
only 30 envelopes. Within this procedure, concealment of
allocation has become redundant as the physiotherapist
who performed the instructions and measures could not in-
fluence group allocation.
Data collection
Demographic (gender, age) and MS disease specific data
(current EDSS) were extracted from patients’ charts; study
specific assessment data were collected by one physiother-
apist, thus avoiding any inter-rater variability. Adverse
events were recorded during or immediately after a visual-
isation session. Withdrawals or other reasons for exclusion
from the study were recorded. For measures at baseline
Fig. 1 CONSORT flow diagram
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[30, 31], the Timed 25-Foot Walk (T25FW) [32] and the
6-Minute Walk Test (6MWT) [33] were used. Baseline
and follow-up assessments were performed at the same
time of the day, in view of daytime fluctuations in fatigue.
Intervention
The intervention of this study consisted of rhythmic
cued motor imagery, the cueing being provided either by
instrumental music or by a metronome, both with add-
itional rhythmic verbal cueing. Study participants were
instructed how to use the rhythmic cued motor imagery
as suggested in previous studies [34, 10]. First, participants
were informed in lay language about the concept of motor
imagery and its application and effects in sports and neu-
rorehabilitation. The approach of rhythmic cued motorimagery was introduced. Secondly, participants learned
about the two perspectives of motor imagery (internal, ex-
ternal), as in clinical practice people use both perspectives
when asked to imagine a movement. Participants were
given practical tips on kinaesthetic imagery of walking,
that is, they were explained to ‘feel’ themselves walking
during the imagery. Finally, for this study, the participants
were asked to imagine themselves walking in various ways,
such as pacing, walking with large steps, raising the fore-
foot during walking, walking fast or stamping, as described
on the CDs prepared by the researcher for this study.
The music type and beat was selected based on a
published summary of practical guidelines and recent
publications [15]: With the metronome cues and music,
rhythmic cueing was in 2/4 or 4/4 metre with strong ON
(on beat 1 or beats 1 and 3) and OFF beat patterns, and it
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(e.g. rhythmic speech ‘step-step’, ‘toe-off ’) [15, 14]. Suitable
rhythmical sequences were cut together and mixed with
instructions on motor imagery of walking at various tempi
and provided on the CD. The same procedure was applied
for the metronome audio mix. According to the Austrian
State Authorized Society of Authors, Composers and
Publishers (AKM), no copyright permission was required
as the music was used for research purposes only. Partici-
pants of all groups received their normal or no treatment.
If participants needed new physiotherapy or drug interven-
tions that could have an impact on walking, they would be
withdrawn from the study.
At the baseline visit, participants in groups A and B re-
ceived the CD, an introduction to motor imagery including
a short practice and instructions from the researcher on the
intervention task. They were asked to practise at home in a
sitting position, with eyes closed and the kinaesthetic mode.
Participants were asked to practise six times a week for
17 min for 4 weeks. Duration of both the practice and the
study were based on the current literature on motor im-
agery, showing an average study duration of 34 days with a
practice intensity of three times a week, for 17 min [10, 6].
The frequency of six times a week was chosen according to
a recommendation by Peiris et al. [35] and a Cochrane
review from Rietberg et al. [36].
Advice was given such as to practise at the best time
of the day in terms of fatigue. Four audio mixes, each
designed in the same way, were on one CD. After each
week, the audio mix was changed with the intention to
maintain attention with the motor imagery [15] and to
facilitate adherence. The researcher called the participants
every week, checking if they had any problems and sup-
porting them in their use of motor imagery. Participants
in the control group were also called weekly by the re-
searcher to pay attention to them and asking for their
health condition. Participants in all groups, including the
control group, received their usual care which consisted of
regular appointments with their physicians and MS spe-
cific immunomodulatory and symptomatic medication.
The researcher is not a member of the MS Clinic team.
Primary outcomes
The feasibility of conducting a larger main study with an
equal or similar study design was tested and reported
descriptively and narratively. These feasibility outcomes
contained recruitment rates, retention rates, safety, compli-
ance, participant acceptability of the study procedures, ad-
verse events and fatigue. Monthly recruitment rates were
recorded. Participant compliance with the interventions
(kinaesthetic motor imagery, melodies, beats, tone pitches
of the metronome cues, verbal cueing) and the acceptability
thereof were recorded during weekly phone calls and at
follow-up. Fatigue was assessed by the MFIS. Fatigue wasmeasured to evaluate whether the interventions or as-
sessments would over-fatigue participants. If so, the
corresponding intervention would be dropped.
Modified fatigue impact scale
The MFIS is a modified form of the Fatigue Impact Scale
[30] and one part of the Multiple Sclerosis Quality of
Life Inventory (MSQLI) [31]. It is a 21-item Likert scale
that evaluates, via self-report, the effects of fatigue on
physical, cognitive and psychosocial functioning, with
higher numbers indicating greater fatigue. The MFIS has
an excellent reliability and moderate to high validity and
responsiveness in people with MS [37, 38] and was rec-
ommended by the MS Outcome Measure Task Force
[39], National MS Society [40] and European Committee
for Treatment and Research in MS (ECTRIMS) Congress
2013 [41].
Secondary outcomes
The secondary outcomes were walking speed as measured
by the T25FW and walking distance as measured by the
6MWT. These measures were chosen for this study, be-
cause they are reliable, valid and sensitive to the expected
changes in the study. They were recommended by the ex-
pert committees described above.
Timed 25-Foot Walk
The T25FW is the most commonly reported short walk-
ing test in people with MS. There is a consensus in the
literature that a change of more than 20 % in walking
speed corresponds to a clinically meaningful functional
change in walking [42, 43]. The T25FW has excellent
validity, reliability and responsiveness in people with MS
[44, 45] and was administered according to instructions
in the Multiple Sclerosis Functional Composite [46].
6-Minute Walk Test
The 6MWT at maximum speed was used to measure
walking distance. There is a discrepancy in the reporting
of the clinically significant change for the 6MWT in
people with MS which was an improvement of 10 %
(21.6 m) as found by Baert et al. [47] and 20 % (88 m)
as shown by Learmonth et al. in a study population
more similar to that of the current study [43]. In the
current study, ≥20 % improvement was considered clinic-
ally significant as a 20 % greater walking distance improves
the individuals’ daily life [48]. The psychometric properties
of the 6MWT have been found to be good to excellent in
an MS population [33, 49]. It was carried out as recom-
mended by the American Thoracic Society-Guidelines.
Walking aids for both the T25FW and 6MWT were used
if required but were documented and kept consistent dur-
ing the two assessments.
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For the primary outcomes, the feasibility criteria were
the recruitment rate and duration, retention rate, safety,
adverse events, compliance, acceptability of the interven-
tions and fatigue. The recruitment rate, consisting of the
eligibility and consent rate, was calculated with 95 % CI
according to Newcombe [50]. The success of recruitment
was assessed (a) in view of a maximum possible duration
of the pilot and main study of 22 months and (b) based
on the potential to recruit the number of participants
estimated by a sample size recalculation. The success of
retention was reported as retention rate, the number of
participants who fully participated in the study until
follow-up and the percentage of missing data. Safety issues
were monitored such as falls during the assessments.
Adverse events, during and after the interventions,
were reported. Severe adverse events would have led to
early study termination. Compliance to the interven-
tions was assessed during weekly phone calls and
follow-up assessments. Participants reported the num-
ber of their rhythmic cued motor imagery practice per
week, and descriptive statistics (median, range) was
used to calculate compliance. Participant acceptability
of the interventions was also assessed during phone
calls and at follow-up assessments. Participants were
asked how much they agreed to the kinaesthetic motor
imagery and whether they had any problems with prac-
tice. They were asked about their agreement to the
melodies and beats of the music and to the tone pitches
of the metronome cues and the verbal cueing. Accept-
ability was reported narratively.
Only descriptive statistics was reported for the primary
and secondary outcomes. Medians (range) were reported
for ordinal data (fatigue), mean (95 % confidence interval
(CI)) were reported for continuous data (walking speed
and walking distance) and raw count (number, %) was
reported for nominal data. Due to the nature of thisTable 1 Participants’ baseline characteristics
Parameter Group A
Music cued motor im
n = 10
Females to males 10:0
Age (years)a 47.3 (38.4, 56.2)
EDSSb 3 (1.5, 4.5)
MFIS total scoreb 35 (3, 67)
Participants with fatigue (MFIS total score ≥38) 4/10
T25FW (s)a 6.1 (4.5, 7.6)
6MWT (m)a 453.1 (365.0, 541.1)
EDSS Expanded Disability Status Scale, MFIS Modified Fatigue Impact Scale, T25FW T
aMean (95 % confidence interval)
bMedian (range)feasibility study, it was decided not to conduct any effi-
cacy statistical tests on the walking and fatigue data.
The sample size for the main study was calculated
using Cohen’s d effect sizes [51] based on the walking
outcomes. Cohen’s d was calculated using the formula
d = (mean 1−mean 2)/corrected pooled standard deviation
(SD). The corrected pooled SD for 80 % of trials was calcu-
lated using the formula (square root from ((SD12 + SD22)/
2))∗1.293 [52]. Effect sizes were calculated with 95 %
CI using an effect size calculator provided by the
Centre for Evaluation and Monitoring at the University
of Durham, UK. The sample size for the main study,
based on effect sizes with 95 % CI, was calculated using
the AI-Therapy online sample size calculator (AICBT
Ltd, Oxford, UK). All statistics were performed using
IBM SPSS software, release 22.0 (IBM Corporation,
Armonk, NY, USA).Results
Baseline characteristics
Participants’ baseline demographic data age and gender
as well as disability in the three groups are shown in
Table 1. Twenty-two females and 8 males were included
in the study, representing a female-to-male ratio of 2.75:1,
corresponding to previously reported data from the UK
with 2.4:1 [53] and from Austria with 2.5:1 [54]. Due to
the random allocation, more females were allocated to the
intervention groups than males. There was no difference
in age, disability (EDSS), MFIS total score, walking speed
(T25FW) and walking distance (6MWT) between the
groups at baseline. Baseline T25FW and 6MWT per-
formances were consistent with results from other studies.
None of the participants required a permanent walking aid;
however, in group A, one participant used two walking
sticks and one participant used one walking stick during all
walking tests.Group B Group C
agery Metronome cued motor imagery Control group
n = 10 n = 10
7:3 5:5
41.8 (34.8, 48.8) 46.1 (39.8, 52.5)
2.5 (1.5, 4.5) 2.5 (1.5, 4.0)
32 (17, 50) 33.5 (0, 48)
2/10 4/10
5.4 (4.5, 6.2) 5.2 (4.3, 6.1)
428.2 (352.8, 503.6) 484.7 (399.5, 569.8)
imed 25-Foot Walk, s seconds, 6MWT 6-Minute Walk Test, m metres
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Recruitment rate and retention rate
According to the research proposal and ethics approval,
the maximum time for the pilot and main study is
22 months, given additional 4 months for data analysis and
interpretation. Feasibility of the main study was assessed
based on recruitment rates (Fig. 1). The MS Clinic Inns-
bruck is currently in care for approximately 2500 people
with MS, and 471 were screened during recruitment
(2 months) of those 189 were eligible. The sample size for
the pilot study was n = 30. The eligibility rate was 40.1 %
(95 % CI 35.8, 44.6 %). Of these 189 participants, 30 were
enrolled to the study (15.9 %, with 95 % CI 11.3, 21.7 %),
and further 103 eligible individuals declared their wish to
participate in the study at a later point in time (54.5 %, with
95 % CI 47.4, 61.4 %). Therefore, it is expected that 1025
(95 % CI 895, 1115) out of 2500 MS Clinic patients are eli-
gible and that 163 (95 % CI 116, 222) people with MS will
participate in the main study. Due to the fact that additional
103 persons were willing to participate at a later point in
time, the actual numbers might be even higher. The ob-
served recruitment rate per month was 12 participants. All
30 participants completed the study, corresponding to a
100 % retention rate (95 % CI 88.6, 100 %). There were no
missing data and no relapses of MS in this study; however,
this cannot be expected for a larger trial. All participants
were included in the analysis in the groups to which they
were originally assigned.
Safety and acceptability
There were no safety issues such as falls during the as-
sessments. Participants were allowed to rest at any time
during instructions and assessments. The home-based
intervention could be practised in a sitting position and
was reported by the participants to be safe and convenient.
Phone calls showed that one participant had initial diffi-
culties with the kinaesthetic motor imagery, but these
problems were reduced through practice. Two participants
reported concentration problems which became better
with practice. One participant in group A reported her
ability to perform motor imagery decreased with increas-
ing music complexity.
All participants in group A reported that they liked
the music melodies, particularly because different music
styles were used and that the beats supported their
motor imagery of walking. Five out of 10 participants in
group B regarded the metronome cues being helpful to
keep the tempo of their imagined steps, 2/10 concerned
them neutral and 3/10 found them boring. All partici-
pants in group B regarded the variety of tone pitches
being acceptable. All but one of the participants (in group
B) reported that the verbal cueing of the researcher facili-
tated their attention with the motor imagery and helped
them to stay with the beat. No other participants reportedproblems, and 8 out of 10 participants in group A and 4
out of 10 in group B reported the intervention as being
pleasurable. To summarise, the intervention was found to
be acceptable despite some initial barriers which would be
worthy of further investigation in the main study.
Adverse events and compliance
There were no reported adverse events related to this
study. The intervention was home-based; therefore, the
researchers had to rely on reported adherence. Participants
reported to have practised median five (range four, six)
times per week. Referring to a proposed practice frequency
of six times per week, compliance was considered good.
Fatigue
As can be seen from Table 2, there was no worsening in
fatigue after the interventions. Fatigue, as assessed by
the MFIS total score, improved from baseline to follow-up
in group A by median −9.5 (range −31, 5) points, in group
B by −13 (range −28, 7) points and in group C by −3
(range −17, 4) points. Based on previous studies, the cutoff
value for MS-related fatigue was set at ≥38 points on the
MFIS total score [55]. Accordingly, 2 out of 10 partici-
pants in all groups A, B and C had fatigue, which was a re-
duction when compared to baseline with 4/10 participants
with fatigue in group A, 2/10 in group B and 4/10 in
group C.
Secondary outcomes
Walking speed
For the walking outcomes (T25FW; 6MWT), means and
95 % CI for participants in groups A, B and C at follow-
up are shown in Table 2. The mean improvement in
walking speed from baseline to follow-up expressed at a
95 % CI was −0.9 s (−1.3, −0.5) in groups A and B, and
the mean worsening was 0.4 s (−0.3, 1.1) in group C.
Based on the literature and clinical judgement, a bench-
mark for a clinically significant change in walking speed
was set at ≥20 %. Three participants in both groups A
and B but no participant in the control group C showed
a clinically meaningful improvement ≥20 % from baseline
to follow-up. The current potential of both interventions
to induce such a clinically significant improvement in the
main study is 30 % (95 % CI 7, 65 %). The two participants
using walking sticks during the assessments did not show
a clinically significant improvement in walking speed
and distance.
Walking distance
The mean improvement in walking distance from base-
line to follow-up expressed at a 95 % confidence interval
in group A was 68.1 m (51.4, 84.7) and in group B
92.9 m (55.2, 130.5), and the mean worsening in group
C was −9.4 m (−35.6, 16.9). Based on the literature and
Table 2 Follow-up data for each study group
Parameter Group A Group B Group C
Music cued motor imagery Metronome cued motor imagery Control group
MFIS total score (points)
At follow-upa 28 (0, 53) 20 (3, 50) 29 (0, 46)
Participants with fatigue (MFIS total score ≥38) 2/10 2/10 2/10
Change to baselinea −9.5 (−31, 5) −13 (−28, 7) −3 (−17, 4)
T25FW (seconds)
At follow-upb 5.2 (3.6, 6.7) 4.5 (3.7, 5.2) 5.5 (4.5, 6.6)
Change to baselineb −0.9 (−1.3, −0.5) −0.9 (−1.3, −0.5) 0.4 (−0.3, 1.1)
Effect sizec 1.27 (0.26, 2.17) 1.27 (0.26, 2.17)
Participants with clinically significant improvement (≥20 %)d 3/10 3/10 0/10
30 % (7, 65 %) 30 % (7, 65 %) 0 % (0)
6MWT (metres)
At follow-upb 521.1 (428.8, 613.5) 521.1 (454.1, 588.0) 475.3 (384.9, 565.8)
Change to baselineb 68.1 (51.4, 84.7) 92.9 (55.2, 130.5) −9.4 (−35.6, 16.9)
Effect sizec 1.91 (0.79, 2.88) 1.72 (0.64, 2.67)
Participants with clinically significant improvement (≥20 %)d 2/10 6/10 0/10
20 % (2, 56 %) 60 % (26, 88 %) 0 % (0)
With walking speed (T25FW), improvement is indicated by a minus and worsening by a plus; with walking distance (6MWT), improvement is indicated by a plus
and worsening by a minus
T25FW Timed 25-Foot Walk, 6MWT 6-Minute Walk Test
aMedian (range)
bMean (95 % confidence interval)
cCohen’s d, with 95 % confidence interval, based on corrected estimates of pooled standard deviation for 80 % of trials [52]
dPercentage (95 % confidence interval)
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cant change in walking distance was set at ≥20 %. Two
participants in group A and six participants in group B
but no participant in group C had a clinically meaningful
improvement ≥20 % from baseline to follow-up. The
current potential of music and metronome cued motor
imagery to induce such a clinically significant improve-
ment in the main study is 20 % (95 % CI 2, 56 %) and
60 % (95 % CI 26, 88 %), respectively.
Implications for main study
From the feasibility and secondary outcomes, results fol-
low that a full-scale RCT is feasible. Requirements devised
for the main study are described in the next paragraphs.
Sample size
The estimated a priori sample size according to the
study protocol was 112–150 participants, as approved by
the ethics committees of the University of Brighton and
Medical University of Innsbruck. On basis of the results
of the walking outcomes (walking speed and walking dis-
tance), which will be the primary outcomes of the main
study, the sample size for the main study was calculated
using the effect sizes with 95 % CI shown in Table 2.
The effect size of the walking speed (T25FW) improve-
ment in both groups was d = 1.27 (95 % CI 0.26, 2.17).The effect size of the walking distance (6MWT) im-
provement in group A was d = 1.91 (95 % CI 0.79, 2.88),
and in group B, it was d = 1.72 (95 % CI 0.64, 2.67), both
based on alpha = 0.05 and 80 % power. Corrected esti-
mates of pooled standard deviation for 80 % of trials were
used for the effect size calculations, as recommended by
Vickers (2003) [52]. Based on the above reported effect
size of d = 1.27, a sample size of 11 participants per group
resulted, whereas effect sizes of d = 1.91 and d = 1.72 re-
quired a sample size of 6 and 7 participants per group, re-
spectively. In view of the large confidence intervals and
based on comparable studies, we used a moderate effect
size of d = 0.64 of the lower bound of the 6MWT im-
provements. The resulting sample size was 40 participants
per group. Comparable motor imagery studies in people
with stroke [8] and rhythmic auditory stimulation studies
in people with MS [22] also found moderate effect sizes.
To our knowledge, no other motor imagery or rhythmic
auditory stimulation studies in people with MS were
conducted that presented effect sizes.
The retention rate in our study was 100 % (95 % CI
88.6, 100 %); therefore, an attrition rate of up to 11 %
might occur. Retention rates in three motor imagery
studies, in a small study in people with MS were 100 %
[6], and in larger studies in people with stroke were
92.6 % [8] and 85.1 % [56], respectively. Thus, our own
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mation of a 15 % attrition rate. Forty multiplied with 3
results in the number of 120. By addition of 15 % (18
participants), a sample size of 138 participants results. In
order to increase power, up to 150 participants will be
aimed at, according to the ethics approval.Randomisation
As can be seen from Table 1, participant allocation was
balanced with regard to age, disability and baseline walk-
ing but unbalanced in terms of gender. Therefore, the
randomisation will be stratified on the three relevant
predictive factors for a change in walking in people with
MS, namely age, gender and disability (EDSS). The stratifi-
cation will help ensure that the intervention and control
groups are similar with respect to patient characteristics.
Stratification requires restricted allocation, typically block-
ing which ensures a balance in sample size across groups.
Therefore, stratified block randomisation in permuted fixed
blocks of three with a computer random number generator
will be performed (Sealed Envelope, London, UK).Allocation concealment
To avoid allocation bias, allocation concealment will be
performed in the main trial. Each participant will have a
unique identification number (ID). A computer generated
randomisation list based on the predefined strata will
be produced by an independent researcher at Medical
University of Innsbruck who will also create sealed opaque
envelopes including group allocation numbers A, B and C.
The envelopes will be stored in a sequentially numbered
order based on the generated list and allocated to each
participant in the order in which they are recruited. Partic-
ipants will be asked to unseal the envelopes themselves
and not to discuss their group allocation until study
completion.Blinding
In the main study, it will be worthwhile to consider
blinding, for two reasons: Participants who are not
aware of their group allocation might less likely show
changes in behaviour, motivation and adherence. If re-
searchers who are collecting the outcome data are not
aware of the participant group allocation, they will not
be influenced by their knowledge in any way. Blinding of
the participants would be feasible by introduction of a
placebo intervention, such as music listening. However,
that would change the study design as it was not tested
in the pilot study, and therefore the study data could not
be used in the main study. Blinding of the researcher
will be possible by involvement of a second researcher
who is responsible for the outcome assessments.Discussion
To our knowledge, this was the first trial to investigate
the impact of rhythmic cued motor imagery on walking in
people with MS. Our pilot study evaluated the feasibility
of the methods used for a larger RCT that will investigate
the effects of rhythmic cued motor imagery on walking
in people with MS. For this purpose, the success of the
feasibility criteria recruitment rate, duration of recruitment,
retention rate, safety, adverse events, compliance, ac-
ceptability of the interventions and fatigue was assessed. It
was evaluated whether music or metronome cued motor
imagery negatively impacted on fatigue which would have
led to dropping one of the intervention arms. In addition,
the group differences between baseline and follow-up on
the secondary outcomes in walking speed and walking dis-
tance were measured. The differences in walking speed
and walking distance was used to recalculate the sample
size for the main study.
We achieved our recruitment target by recruiting 12
participants per month, an eligibility rate of 40.1 % out of
2500 MS Centre patients, a consent rate of 15.9 % and
additional 54.5 % of eligible patients who expressed their
interest to participate. Following from this, approximately
12 months are estimated for the main study recruitment, a
time period which is well below our maximum available
time period of 20 months. The retention rate in our study
was 100 %, compared to motor imagery studies with re-
tention rates of 100 % in people with MS [6], as well as
92.6 % [8] and 85.1 % [56] in people with stroke. As we
cannot expect to have a 100 % retention rate in a larger
trial, we based the sample size calculation on an 85 %
retention rate.
There were no safety issues during the assessments
and no adverse events associated with the interventions.
Participants considered the rhythmic cued motor im-
agery interventions to be safe and convenient because
they could practise while seated in their homes. Eight
out of 10 participants in the music cued motor imagery
group, and 4 out of 10 in the metronome cued motor
imagery group regarded the intervention to be pleasur-
able. This result is not surprising as metronome cues are
monotonous, whereas music melodies and rhythms carry
emotion and are known to have an influence on mood,
the desire to move and work output. In the main study,
additional quality of life measures will be used to assess
the impact of the music and metronome cued motor im-
agery on psychological functioning. The majority of partic-
ipants reported the music and metronome cueing being
helpful to keep the tempo of their imagined steps and the
verbal cueing being supportive to maintain their attention
and stay with the rhythm; thus, the same cueing types will
be used in the interventions of the main study. The overall
compliance was good with a practice frequency per week
of median 5 (range 4, 6). We expect a similar compliance
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acceptable, if not pleasurable to participants.
The intervention of our study was home-based which
might have had an impact on adherence, in two respects:
first, participants were responsible to comply with the
practice frequency of six times a week for 4 weeks as it
would not be practical to supervise on a 6× week basis.
We had to rely on the participants’ reports of their adher-
ence which was noted by the researcher during weekly
phone calls and follow-up assessments. Secondly, the set-
ting seemed to be beneficial insofar as the participants were
not required to travel for the intervention, as it is known
that many people with MS have difficulties with driving a
car and walking.
We observed a mild improvement in fatigue in all
groups at follow-up when compared to baseline. This
means that none of the interventions worsened fatigue
so that both the music and metronome cued motor im-
agery arm will be used in the main study. Interestingly,
fatigue was also slightly improved in the control group,
probably due to motivational aspects related to being in
a study.
Motor imagery with instrumental music as well as
motor imagery with metronome cues improved walking
speed and walking distance in the intervention groups
compared to controls. From a patient viewpoint, an im-
provement in walking speed is only useful if it reaches
clinical significance, because only in such a case the
intervention benefits the person in their activities of
daily living. Recent studies showed that a ≥20 % change
in walking speed exceeds the day-to-day differences in
participants’ walking performance and the variability of
the measurements, and therefore, such a change can be
considered a clinically meaningful change [42, 43]. In-
deed, three participants in our study in both groups A
and B showed a clinically significant improvement in
walking speed which is consistent with a current 30 %(95 %
CI 7, 65 %) potential for such an improvement in the main
study.
Rhythmic cued motor imagery also improved walking
distance as measured by the 6MWT in participants of
both intervention groups when compared to the control
group. Learmonth et al. found that a ≥20 % improve-
ment might be regarded clinically meaningful [43]. Such
an improvement might enable persons to maintain their
independence and to increase their range of activities,
which might influence their quality of life and their abil-
ity to work. In our study, two participants in group A
and six participants in group B reached a clinically sig-
nificant improvement in walking distance, consistent
with a current potential of intervention A to induce such
an improvement in the main study of 20 % (95 % CI 2,
56 %) and in group B of 60 % (95 % CI 26, 88 %). In con-
trast to our study, in their large multicentre study, Baertet al. reported a change of 10 % (21.6 metres) in the
6MWT measures to be sufficiently large for a clinically
meaningful improvement [47]; however, their study
population had more severe disability.
Based on our clinical experience, our suggestions were
that the participants might benefit more from the rhyth-
mic cued motor imagery if they would be able to truly
understand what to practice. Hence, our participants
were thoroughly informed on the motor imagery and
rhythmic cueing. Our approach was in line with other
studies who explicitly introduced participants to the motor
imagery theory and to the perspective to be adopted during
the intervention [57, 58]. A motor imagery familiarisation
was carried out similar to that proposed by Wondrusch
and Schuster-Amft in 2013 [34].
Our strategy to facilitate motor imagery was to add ex-
ternal rhythmic auditory cues, which has been effective
in other studies [59, 23]. Besides music and metronome
cues, rhythmic verbal cueing, in accordance with the
cueing tempo, was used to accentuate the timing structure
of the rhythmic cued motor imagery. A similar approach
had also been proposed by the recent literature on the use
of patterned sensory enhancement for facilitation of
complex movements in people with neurologic dis-
eases including MS [15, 14]. The additional cueing
might have supported the participants to practise the
motor imagery, and the verbal cueing might have helped
to maintain the temporal patterns of walking during the
motor imagery [60].
As far as we know, our participants were able to per-
form motor imagery. Our results seem to be in contrast
to previous studies demonstrating a lower capacity for
motor imagery in people with MS [61, 12]. However,
these authors linked impaired motor imagery in this
population particularly to cognitive dysfunction [61, 12]
and depression [62]. Therefore, persons with cognitive
impairment and depression were excluded from our
study. Several studies used patient-rated questionnaires,
such as the Kinaesthetic and Visual Imagery Questionnaire
to assess the motor imagery ability in their participants
[12, 62]. Our study could have used this patient-rated
questionnaire, but our participants were called weekly
to ask for any problems with kinaesthetic motor imagery,
and they were supported accordingly. In addition, all
motor imagery ability studies in people with MS were
experimental studies with no long-term training effects,
in contrast to our 4 weeks duration study with 24 train-
ing sessions which might have enhanced the mental
representation [63].
This study was conducted as a single-centre study,
which might be an advantage because the study was im-
plemented in the same way with all participants. Only
outcomes that are reliable and valid in the MS popula-
tion were used. Application of these measures facilitates
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meta-analysis at a later point in time.
There are several possible limitations to this pilot study.
Participants in all groups including the control group were
called weekly, asking about their health condition. This
means we spent time on the participants of the control arm
and accompanied them over the 4 weeks study period,
which probably contributed to their improvement in fa-
tigue. Nevertheless, participants of the intervention groups
received additional motor imagery familiarisation and the
researcher’s instructions and verbal cueing on the CDs. The
extra attention paid to participants in groups A and B
might have increased their motivation to walk faster and a
larger distance. However, after study completion several
participants decided to continue their practice since their
walking had improved to such a great extent. The study
was underpowered because of the small sample size, but
this was a pilot study to enable us to calculate the required
sample size for the main trial. The results are to be consid-
ered preliminary, and they cannot be generalised yet to a
larger population of people with MS. A subsequent well-
powered main study is being conducted.
There was an imbalance of groups with respect to gender.
To ensure a balanced group allocation in the main study,
the randomisation will be stratified on the predictive factors
gender, age and disability. To guarantee a balanced group
size, block randomisation in permuted blocks will be used.
Another possible limitation of the study is the use of a
single physiotherapist to give instruction to participants
and undertake all measurements. To overcome this
limitation, a script was used and all instructions and
support were carried out consistently. Finally, the lack
of blinding is another limitation and is a challenge in
physiotherapy trials. However, blinding of the partici-
pants would not have been possible as they would have
realised their group allocation. It is unlikely that blind-
ing of the researcher would have made any difference
to the findings as both walking tests were performed
according to internationally recognised guidelines and
instructions. However, it is advisable to implement blinding
of the researcher in the main study which can be done by
employment of a second researcher responsible for the as-
sessments. The randomisation procedure should have made
allocation concealment redundant as the researcher could
not influence participant allocation to groups. To prevent
possible allocation bias in the main study, allocation con-
cealment will be performed.
Conclusions
The results from our pilot study showed that a larger
main study is feasible to investigate the effects of rhythmic
cued motor imagery on walking, fatigue and quality of life
in people with MS. Success of the feasibility criteria
demonstrated that no changes to the interventions andassessments will be required. Based on the walking im-
provements, a sample size of 46 participants in three
groups, that is a total sample size of 138 participants by
inclusion of 15 % attrition, was calculated for the main
study. To avoid bias, stratified blocked randomisation,
allocation concealment and blinding will be used. The
preliminary improvements in walking speed, walking dis-
tance and fatigue need to be confirmed in a larger trial.
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